This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Zambon S.p.a.. Active years: 1987-2009.
Location History:
- Vacallo, CH (1987)
- Origlio, CH (1989 - 2009)
Company Filing History:
Years Active: 1987-2009
Title: **The Innovations of Valter Gianesello**
Introduction
Valter Gianesello is a notable inventor based in Origlio, Switzerland. With a total of four patents to his name, Gianesello has made significant contributions to the field of pharmaceuticals, particularly in developing formulations that enhance patient compliance for younger populations.
Latest Patents
One of his most recent inventions includes a chewable tablet containing lysine. This innovative tablet is specifically designed to increase compliance among humans, particularly children and juveniles. By providing a chewable option, Gianesello aims to improve medication adherence in younger patients who may find traditional tablets challenging to swallow.
Career Highlights
Throughout his professional journey, Valter Gianesello has been associated with esteemed companies such as Zambon S.p.A. and Boehringer Ingelheim International GmbH. His experience in these organizations has significantly influenced his inventive contributions and has allowed him to work on various crucial pharmaceutical projects.
Collaborations
In addition to his work within these companies, Gianesello has collaborated with esteemed colleagues like Annibale Gazzaniga and Federico Stroppolo. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and expertise, which has been instrumental in advancing their projects.
Conclusion
Valter Gianesello's work demonstrates a commitment to improving health outcomes through innovative pharmaceutical solutions. His inventions, particularly the chewable lysine tablet, highlight the importance of compliance in medication, especially for younger patients. As he continues his work in the industry, Gianesello remains an influential figure in the realm of pharmaceutical innovations.